Danaher Co. (DHR) CFO Matthew Mcgrew Sells 22,738 Shares

Danaher Co. (NYSE:DHR) CFO Matthew Mcgrew sold 22,738 shares of Danaher stock in a transaction on Monday, April 29th. The shares were sold at an average price of $130.89, for a total value of $2,976,176.82. Following the sale, the chief financial officer now directly owns 27,534 shares of the company’s stock, valued at approximately $3,603,925.26. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Shares of DHR opened at $131.10 on Friday. The company has a market cap of $93.82 billion, a PE ratio of 29.00, a price-to-earnings-growth ratio of 2.53 and a beta of 1.02. The company has a current ratio of 2.18, a quick ratio of 1.74 and a debt-to-equity ratio of 0.32. Danaher Co. has a 12 month low of $94.59 and a 12 month high of $134.67.

Danaher (NYSE:DHR) last issued its earnings results on Thursday, April 18th. The conglomerate reported $1.07 earnings per share for the quarter, beating analysts’ consensus estimates of $1.01 by $0.06. The firm had revenue of $4.88 billion for the quarter, compared to analyst estimates of $4.80 billion. Danaher had a net margin of 12.04% and a return on equity of 11.61%. The company’s quarterly revenue was up 3.9% on a year-over-year basis. During the same quarter last year, the business posted $0.99 earnings per share. As a group, equities analysts predict that Danaher Co. will post 4.77 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be paid a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.52%. The ex-dividend date of this dividend is Thursday, June 27th. Danaher’s dividend payout ratio (DPR) is currently 15.04%.

A number of equities analysts have recently commented on the company. Zacks Investment Research lowered Danaher from a “hold” rating to a “sell” rating in a research note on Tuesday, April 30th. Needham & Company LLC reaffirmed a “buy” rating and set a $141.00 price objective (up from $138.00) on shares of Danaher in a report on Wednesday, April 17th. Jefferies Financial Group lifted their price objective on Danaher to $140.00 and gave the company a “buy” rating in a report on Tuesday, February 26th. Deutsche Bank boosted their target price on Danaher to $130.00 and gave the stock a “buy” rating in a report on Tuesday, February 26th. Finally, UBS Group upped their target price on shares of Danaher from $125.00 to $144.00 and gave the company a “buy” rating in a research report on Tuesday, February 26th. Two equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Danaher has a consensus rating of “Buy” and a consensus target price of $131.75.

Institutional investors and hedge funds have recently bought and sold shares of the business. Canton Hathaway LLC increased its stake in Danaher by 8.7% in the first quarter. Canton Hathaway LLC now owns 12,886 shares of the conglomerate’s stock valued at $1,701,000 after purchasing an additional 1,036 shares in the last quarter. Abacus Planning Group Inc. increased its position in shares of Danaher by 52.3% during the fourth quarter. Abacus Planning Group Inc. now owns 9,979 shares of the conglomerate’s stock worth $225,000 after acquiring an additional 3,428 shares in the last quarter. Municipal Employees Retirement System of Michigan bought a new stake in shares of Danaher during the fourth quarter worth about $1,705,000. IHT Wealth Management LLC increased its position in shares of Danaher by 5.1% during the fourth quarter. IHT Wealth Management LLC now owns 2,023 shares of the conglomerate’s stock worth $209,000 after acquiring an additional 98 shares in the last quarter. Finally, Advisor Partners LLC increased its position in shares of Danaher by 17.3% during the fourth quarter. Advisor Partners LLC now owns 19,477 shares of the conglomerate’s stock worth $2,008,000 after acquiring an additional 2,868 shares in the last quarter. 76.98% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: “Danaher Co. (DHR) CFO Matthew Mcgrew Sells 22,738 Shares” was originally reported by Mayfield Recorder and is the sole property of of Mayfield Recorder. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international copyright and trademark laws. The correct version of this report can be viewed at https://mayfieldrecorder.com/2019/05/18/insider-selling-danaher-co-dhr-cfo-sells-2976176-82-in-stock.html.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Featured Article: No Load Funds

Insider Buying and Selling by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.